Elevated blood pressure is a common side effect of VEGF inhibitors in cancer treatment, impacting patient safety and treatment efficacy. To address this, effective management—including regular monitoring and potential adjustments to treatment—is crucial, making robust strategies essential to managing these challenges effectively. NCODA’s VEGF Inhibitor-Induced Hypertension PQI provides actionable strategies and clinical management tips to help clinicians address this issue and enhance #patientcare. Explore this resource:?https://bit.ly/47uYltB
关于我们
NCODA is a grassroots, not-for-profit organization, founded to strengthen community oncology practices with dispensing services. NCODA is addressing the growing need for dispensing cancer clinics to improve operations at the pharmacy level in order to deliver quality and sustainable value to all stakeholders involved in the care of cancer patients’ receiving oral and IV therapy. NCODA brings value to practices through adoption of Quality Standards, sharing of best practices and improving financial viability. Through NCODA, dispensing practices will be in a position to further demonstrate their high quality and patient-centered focus. With NCODA’s value proposition, community oncology practices will be able to convey to all stakeholders why it is vitally important for a patient’s treatment to remain with their oncologist from first fill through refills. This value proposition creates a win-win solution for all stakeholders involved in oral chemotherapy including patients, employers, payers, practices, pharmaceutical companies, advocacy groups, professional organizations, PBMs, GPOs, foundations, legislators, and state boards of pharmacy. NCODA’s membership is comprised of like-minded community cancer centers from across the country and is rapidly spreading to additional states who operate a dispensing platform. NCODA is rapidly growing and has expanded to represent over 3,000 prescribers nationally. NCODA will always be independent for its stakeholders, as it formulates a collaborative drug therapy management model which is so vitally important to the increasing number of patients prescribed oral chemotherapy and the providers involved in their care.
- 网站
-
https://www.ncoda.org
NCODA的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 11-50 人
- 总部
- Cazenovia，NY
- 类型
- 非营利机构
- 创立
- 2015
- 领域
- Physician Office Dispensing、Oral Oncolytics、Quality Standards和Practice Efficiency
地点
-
主要
获取路线
PO Box 468
US，NY，Cazenovia，13035
NCODA员工
动态
-
Understand how zanubrutinib’s efficacy and consistent safety in CLL and SLL can transform treatment approaches. Join us?on Tuesday, September 17 at 2 pm EST to learn from Kirollos Hanna, PharmD, BCPS, BCOP, FACCC, who will?cover its uniform benefits across patient subgroups, 24-hour BTK inhibition, and flexible dosing options. Gain actionable insights to improve your patient care and treatment decisions. For any questions or to request the webinar link, please contact us at?[email protected].
-
-
FDA approves atezolizumab and hyaluronidase-tqjs for subcutaneous injection for all adult indications as the intravenous formulation of atezolizumab. https://lnkd.in/gHNftUWD
-
Handling difficult conversations in patient care is both challenging and essential. This week, we sit down with Dr. Toby Campbell MD, MS, FAAHPM, a communication and palliative care expert, and Professor at the University of Wisconsin-Madison. He shares insights on managing these crucial talks and offers practical strategies to enhance patient interactions and improve care outcomes. Tune in to learn how effective communication can transform #patientcare and make a difference in the most challenging medical situations. Streaming now wherever you listen to podcasts or at: https://lnkd.in/ghbfxT8X?
-
Oncology nurses - join us?TODAY at 3 PM EST for?our?Nursing Community monthly gathering! NCODA's Fellow Daisy Doan, PharmD,?will provide an overview of the transitions of care (TOC) process and the collaborative role nurses and pharmacists have in closing gaps within TOC. We’ll also hear from our Nurse in Focus, Debbie Shapert, MSN, RN, OCN, from Maryland Oncology Hematology, who will discuss her work with new nurse onboarding, annual competencies, and pilot programs. Join here:?https://lnkd.in/eyeGJdGW
-
-
Acronyms are a standard fixture in oncology; decoding them can often create confusion despite their crucial role in patient care. At the upcoming NCODA 2024 International Fall Summit in Orlando, October 23-25, Katie Richardson, PharmD, BCOP (Jennie Stuart Health), will unravel these abbreviations in the session “Alphabet Soup: Breaking Down Acronyms in Pathology and Cancer Care." Discover the meanings of these terms, the timing and significance of various tests, and how test results impact treatment decisions. View the complete agenda and register:?https://lnkd.in/enGh5fug
-
-
Researchers from the University of Michigan analyzed the lingering financial impact of cancer on survivors across a range of cancer types and community level social determinants of health and recently shared the information in JAMA Network Open. The high-level findings reinforce the importance of deeply understanding the impact of cancer on each patient, and to support them beyond their diagnosis and treatment.
Risk Factors of Cancer-Related Financial Hardship Among Cancer Survivors
jamanetwork.com
-
Toripalimab offers new possibilities for treating nasopharyngeal carcinoma. Join us TODAY at 2 PM EST to hear from Dr. Jong Chul Park of Massachusetts General Hospital as he shares insight?into the clinical aspects and management strategies for this treatment. Follow the link to join:?https://lnkd.in/eyeGJdGW
-
-
Don't forget! You have until this Friday, September 13, to submit your nomination for the 2024 Living The Mission Award! This is your chance to shine a spotlight on someone who exemplifies NCODA’s mission. Be part of the celebration at our 2024 International Fall Summit, where we’ll reveal the award recipient(s). Learn more & submit your nomination:?https://lnkd.in/gjGXpXMv
-
-
Get ready for a packed week of expert-led webinars covering a wide range of topics. From the clinical use of toripalimab in nasopharyngeal carcinoma to insights on repotrectinib and pharmacy technician roles, plus nursing perspectives and?valuable NMDP resources for patient care! Explore the full lineup:?https://lnkd.in/eyeGJdGW
-